-
Mashup Score: 02023: The Year of the Site. We Are Listening. | Medable - 1 year(s) ago
Collaboration with Clinical Research Sites is key to drive innovation and decentralized clinical trial adoption.
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
Check out a brief recap of what topics dominated this year’s SCOPE conference in order to get a sense of where our industry’s headed in 2023.
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet-
“My CTA to you is to learn this landscape of clinical trial solutions. You have the power to make trials the best they can be for your mom, and for every patient.” — One of our favorite quotes at this year's SCOPE Summit. Read our other highlights here: https://t.co/e4DYu7kylp https://t.co/if04EzDUAj
-
-
Mashup Score: 0Patient perspectives: a year of pharma webinars showcase what’s working and what needs work | Medable - 1 year(s) ago
See patients and caregivers’ thoughts on what pharma has gotten right with digital technology, and what needs more work in this blog.
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet-
Find out from Medable's Patient Caregiver Network what our industry currently does right for patients & caregivers during decentralized/hybrid trials, & what still needs work, in their summary of 25 life science events. Reah here: https://t.co/YXNUoEL76o #clinicaltrials
-
-
Mashup Score: 1See you at SCOPE 2023! | Medable - 1 year(s) ago
We’re thrilled to be joining the SCOPE Summit, February 6th-9th, in Orlando, FL. Check out our speaking sessions and Medable booth at this year’s conference.
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet-
Transformation depends on all of us. Partnerships like the one between Medable & @ixlayer_ are helping studies attract and retain more participants, offering an improved patient experience from recruitment through LTFU. Find us at SCOPE to learn more: https://t.co/GFvy0Tz5a9 https://t.co/C9VJIhku0j
-
-
Mashup Score: 0What does the new European Medicine Regulatory Network recommendation paper on decentralized elements in clinical trials tell us? | Medable - 1 year(s) ago
The message is clear: the inclusion of decentralised elements in clinical research does not change the guiding principles of clinical trial conductWhile the acronym DCT (Decentralised Clinical Trial) may be relatively new, if we ask if the inclusion of decentralised elements in clinical trials is new, the answer is No. What is new, is the wider recognition by the clinical development community…
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet-
"The message is clear: the inclusion of decentralized elements in clinical research does not change the guiding principles of clinical trial conduct", states Medable's Flo Mowlem. Read Flo's full perspective on EMRN's recent DCT recommendations, here: https://t.co/Qi8eHZfC5e
-
-
Mashup Score: 0New EU Regulatory Recommendations for Decentralized Trials Keep Focus on Patients and Sites | Medable - 1 year(s) ago
As clinical trials rapidly modernize, government regulators work to evolve even as the same core principles apply.
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet-
Medable's Mohammed Ali and Kevin Potgieter summarize key takeaways from the EU regulatory recommendations for decentralized trials. Read it here:https://t.co/m4MgWYbDlg
-
-
Mashup Score: 1See you at SCOPE 2023! | Medable - 1 year(s) ago
We’re thrilled to be joining the SCOPE Summit, February 6th-9th, in Orlando, FL. Check out our speaking sessions and Medable booth at this year’s conference.
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet-
Team Medable is thrilled to be joining the 2023 SCOPE Summit. Be sure to check out our speaking sessions with Alison Holland & Mohammed Ali, & meet the team at booth #613. You can also schedule meetings in advance with one of our experts, here ➡️: https://t.co/GFvy0Tz5a9 https://t.co/b2y27sQm36
-
-
Mashup Score: 3Five Myths About eConsent: True or False? | Medable - 1 year(s) ago
While clinical trials have used digital tools to various extents before 2020, the COVID-19 pandemic showed just how effective — and necessary — they can be.
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet-
While eConsent’s benefits are well-documented, misconceptions around its use & capabilities persist. As our industry continues to follow new paths to digitization, it’s important to debunk the most prevalent myths — both old & new. Learn more: https://t.co/w4YCYzuHo7 https://t.co/FsT0v93QEu
-
-
Mashup Score: 0Oncology | Medable - 1 year(s) ago
Medable’s oncology suite simplifies data collection for sites and sponsors while keeping patients safe, comfortable, and engaged from any location.
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet-
Oncology trials are notoriously complex, but meeting patients where they want, while providing real-time help & insights to sites & sponsors, improves the study experience for everyone when it matters most. Learn more about Medable's Oncology Offering: https://t.co/OHIL6FHliS https://t.co/XrvzhRZkbr
-
-
Mashup Score: 0See you at SCOPE 2023! | Medable - 1 year(s) ago
We’re thrilled to be joining the SCOPE Summit, February 6th-9th, in Orlando, FL. Check out our speaking sessions and Medable booth at this year’s conference.
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet-
We're excited to attend this year's SCOPE Summit & meet with industry leaders who share a common goal - To improve the quality of patients' lives through innovative digital health solutions. Click here to arrange a meeting with the Medable team at SCOPE: https://t.co/GFvy0Tz5a9 https://t.co/aJM51sKdAQ
-
Medable is committed to maximizing the benefits of digital trials for all stakeholders, by proactively listening to sites to overcome the barriers to their adoption (which may differ from what you'd assume). Learn more: https://t.co/MGA5YBQfsI ____ #clinicaltrials https://t.co/9qetSg0amk